THC vs TOI
THC: A nationwide hospital and ambulatory surgery network with deep expertise in acute, specialty, and emergency care, backed by value-based care and revenue cycle management services. TOI: The Oncology Institute is a value-based oncology care provider that manages outpatient cancer treatment through a national network of clinics and integrated specialty pharmacies.
Side-by-side fundamentals
| Metric | THC | TOI | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $195.35 | $5.29 | |
| Market cap as of 2026-07-23 | $16.9B | $529M | |
| P/E as of 2026-07-23 | 9.94 | n/a | |
| PEG as of 2026-07-23 | 0.38 | n/a | |
| Net margin as of 2026-07-23 | +7.8% | -8.0% | THC higher |
| Gross margin as of 2026-07-23 | +82.5% | +15.1% | THC higher |
| Operating margin as of 2026-07-23 | +17.6% | -6.0% | THC higher |
| ROE as of 2026-07-23 | +40.6% | -482.6% | THC higher |
| ROA as of 2026-07-23 | +5.7% | -26.5% | THC higher |
| Debt / equity as of 2026-07-23 | 2.74 | 14.58 | THC lower |
| Revenue growth (YoY) as of 2026-07-23 | +6.6% | +35.4% | TOI higher |
| Revenue CAGR (3y) SEC XBRL | +3.6% | +25.8% | TOI higher |
| Beta as of 2026-07-23 | 1.27 | 0.36 | |
| 1-year return as of 2026-07-22 close | +25.2% | +59.2% | TOI higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.